Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 08, 2022

Schoen v. Eiger BioPharmaceuticals, Inc. et al

Track this case

Case Number:

3:22-cv-06985

Court:

California Northern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Richard Seeborg

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. November 08, 2022

    Biopharma Co. Hit With Investor Action Over COVID Treatment

    Eiger BioPharmaceuticals Inc. was hit with a proposed class action in California federal court on Tuesday by an investor who claims the company overstated the likelihood that its experimental treatment for COVID-19 would get emergency use authorization from the U.S. Food and Drug Administration.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login